- $166.71bn
- $229.34bn
- $58.50bn
- 58
- 59
- 88
- 77
Pfizer Inc - Pfizer Statement on CHANTIX (varenicline) Labeling Update in the Un
AnnouncementPfizer Inc - Clinical Trials
AnnouncementPfizer Inc New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics
AnnouncementPfizer Inc Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer
AnnouncementPfizer Inc - Statement re: PCH business
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc Pfizer and Medicines for Malaria Venture Advancing International Rese
AnnouncementPfizer Inc - Pfizer Statement on Exubera Labeling Update in the United States
AnnouncementPfizer Inc - New Preliminary Phase II Data Show Anti-Tumor Activity of Single-Ag
AnnouncementPfizer Inc - Pfizer Names Frank A. DAmelio Chief Financial Officer
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Adding Lipitor Early to Effective Blood Pressure Treatment Provided
AnnouncementPfizer Inc - Pfizer to Advance Three Key Oncology Compounds into Phase 3 Trials
AnnouncementPfizer Inc - Lipitor patent Netherlands
AnnouncementPfizer Inc - Pfizer Extends Subsequent Offering Period of Tender Offer for Share
AnnouncementPfizer Inc - Pfizer Analyst Meeting
AnnouncementPfizer Inc - Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Facto
AnnouncementPfizer Inc - Pfizer to Advance Three Key Oncology Compounds into Phase 3 Trials
AnnouncementPfizer Inc - Regulatory Approval
Announcement